References
- Mailloux L U, Bellucci A G, Wilkes B M, Napolitano B, Mossey R T, Lesser M, Bluestone P A. Mortality indialysis patients: analysis of the causes of death. Am J Kidney Dis 1991; 18: 326–335
- Odeberg H, Olsson I, Thysell H. The effect of uremic serum on granulocyte iodination capacity. Trans Am Soc Artif Int Organs 1973; 19: 484–486
- Ringoir S MG, Van Landschoot N, De Smet R. Inhibition of phagocytosis by a middle molecular fraction from ultrafiltrate. Clin Nephrol 1980; 13: 109–112
- Ritchey E E, Wallin J D, Shah S V. Chemiluminescence and superoxide anion production by leukocytes from chronic hemodialysis patients. Kidney Int 1981; 19: 349–358
- Briggs W A, Sillix D H, Mahajan S, McDonald F D. Leukocyte metabolism and function in uremia. Kidney Int 1983; 24(suppl 16)S93–S96
- Rhee M S, McGoldrick M D, Meuwissen H J. Serum factor from patients with chronic renal failure enhances polymorphonuclear leukocyte oxidative metabolism. Nephron 1986; 42: 6–13
- Hirabayashi Y, Kobayashi T, Nishikawa A, Okazaki H, Aoki T, Takaya J, Kobayashi Y. Oxidative metabolism and phagocytosis of polymorphonuclear leukocytes in patients with chronic renal failure. Nephron 1988; 49: 305–312
- Lucchi L, Cappelli G, Acerbi M A, Spattini A, Lusvarghi E. Oxidative metabolism of polymorphonuclear leukocytes and serum opsonic activity in chronic renal failure. Nephron 1989; 51: 44–50
- Paul J L, Roch-Arveiller M, Man N K, Luong N, Moatti N, Raichvarg D. Influence of uremia on polymorphonuclear leukocytes oxidative metabolism in end-stage renal disease and dialyzed patients. Nephron 1991; 57: 428–432
- Vanholder R, Ringoir S, Dhondt A, Hakim R, Waterloos M A, Van Lantschoot N, Gung A. Phagocytosis in uremic and hemodialysis patients: a prospective and cross sectional study. Kidney Int 1991; 39: 320–327
- Matsumoto T, Kubo S, Takahashi K, Haraoka M, Tanaka M, Kumazawa J, Yoshimine K, Fukumitsu T, Mihara Y, Takayama K. Suppressive effect of sera from patients undergoing chronic hemodialysis on neutrophil chemiluminescence response. Renal Failure 1993; 14: 529–532
- Vanholder R, Dell'Aquila R, Jacobs V, Dhondt A, Veys N, Waterloos M A, Van Landschoot N, Van Biesen W, Ringoir S. Depressed phagocytosis in hemodialyzed patients: in vivo and in vitro mechanisms. Nephron 1993; 63: 409–415
- Allen R C, Stjernholm R L, Steele R H. Evidence for the generation of an electronic excitation state(s) in human polymorphonuclear leukocytes and its participation in bactericidal activity. Biochem Biophys Res Commun 1972; 47: 679–684
- Wilson M E, Trush M A, Van Dyke K, Kyle J M, Mullett M D, Neal W A. Luminol-dependent chemiluminescence analysis of opsonophagocytic dysfunctions. J Immunol Meth 1978; 23: 315–326
- Easmon C SF, Cole P J, Williams A J, Hastings M. The measurement of opsonic and phagocytic function by luminol-dependent chemiluminescence. Immunology 1980; 41: 67–74
- Babb A L, Farrell P C, Uvelli D A, Scribner B H. Hemodialyzer evaluation by examination of solute molecular spectra. Trans Am Soc Artif Int Organs 1972; 18: 98–105
- Man N K, Terlain B, Paris J, Werner G, Sausse A, Funck-Brentano J L. An approach to “middle molecules” identification in artificial kidney dialysate, with reference to neuropathy prevention. Trans Am Soc Artif Int Organs 1973; 19: 320–324
- Djukanovic L JD, Mimic-Oka J I, Potic J B. The effects of hemodialysis with different membranes on middle molecules and uremic neuropathy. Int J Artif Organs 1989; 12: 11–19
- Dukanovic L, Petrovic J, Potic J. Middle molecular weight substances and uremic polyneuropathy. Acta Med Jug 1990; 44: 117–128
- Man N K, Cuille G, Zingraff J, Boudet J, Sausse A, Funck-Brentano J L. Uremic neurotoxin in the middle molecular weight range. Artif Int Organs 1980; 4: 116–120
- Funck-Brentano J L, Man N K, Sausse A, Cueille G, Zinfraff J, Drueke T, Jungers P, Billon J P. Neuropathy and “middle” molecule toxins. Kidney Int 1975; 7: S352–S356
- Kumae T, Sugawara K. A simultaneous multiple measurement system of neutrophil chemiluminescence. Acta Haematol Jpn 1987; 50: 949–957
- Kournikakis B, Simpson M. Optimization of a phagocyte microplate chemiluminescent assay. J Biolumin Chemilumin 1995; 10: 63–67
- Asaba H, Bergström J, Fürst P, Gordon A, Groth C G, Oules G R, Zimmerman L. The effect of renal transplantation on middle molecules in plasma and urine. Clin Nephrol 1977; 8: 329–334